Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
758,321
-
Shares change
-
+24,505
-
Total reported value, excl. options
-
$2,268,277
-
Value change
-
+$89,233
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$2.98
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2025
30 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q3 2025.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 758,321 shares
of 66,587,586 outstanding shares and own 1.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (297,038 shares), GEODE CAPITAL MANAGEMENT, LLC (104,546 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (44,682 shares), RENAISSANCE TECHNOLOGIES LLC (41,296 shares), STATE STREET CORP (40,300 shares), SeaCrest Wealth Management, LLC (34,954 shares), Grey Ledge Advisors, LLC (30,000 shares), BlackRock, Inc. (26,666 shares), and NORTHERN TRUST CORP (19,273 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.